Trial intelligence / Profile preview

Opioid Sparing Analgesia: Intraoperative Infusion Dexmedetomidine Versus Lidocaine for Intracranial Surgeries in Children

NCT04535089Phase 2Completed

Sponsor
Zagazig University
Start
Oct 2020
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine in pain, sponsored by Zagazig University. Started Oct 2020; status: completed.

02

Drugs

dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03

Conditions

pain

Beyond the preview

Go deeper on NCT04535089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04535089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call